{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:03:23Z","timestamp":1793624603629,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101003666"],"award-info":[{"award-number":["101003666"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ymthe.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T03:22:02Z","timestamp":1704943322000},"page":"540-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T\u00a0cells in protection and disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Jingyi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar Ravenna","family":"Bangalore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Nikouyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Appelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Nacimento","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pasetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Grabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Szekely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Szakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Tuvesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Karin","family":"Gidlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cadossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Salati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Tegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Frelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirazimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaf","family":"Ahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-5132","authenticated-orcid":false,"given":"Matti","family":"S\u00e4llberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in\u00a0vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)00743-7","article-title":"Where is the next SARS-CoV-2 variant of concern?","volume":"399","author":"Dennehy","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib5","article-title":"Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore","volume":"29","author":"Tan","year":"2022","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.ymthe.2024.01.007_bib6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41564-022-01163-3","article-title":"Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2","volume":"7","author":"Newman","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron Variant from Previous SARS-CoV-2 Infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41590-022-01351-7","article-title":"Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4","volume":"23","author":"Tye","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T\u00a0cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T\u00a0cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.01.007_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215821","article-title":"A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T\u00a0cells","volume":"14","author":"Appelberg","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01279-20","article-title":"The SARS-CoV-2\u00a0N Protein Is a Good Component in a Vaccine","volume":"94","author":"Ahl\u00e9n","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib13","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1038\/s41467-022-31721-6","article-title":"A third vaccination with a single T\u00a0cell epitope confers protection in a murine model of SARS-CoV-2 infection","volume":"13","author":"Pardieck","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12985-015-0422-1","article-title":"Bat origin of human coronaviruses","volume":"12","author":"Hu","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2024.01.007_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.01.007_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/infdis\/jiaa036","article-title":"Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections","volume":"223","author":"Maravelia","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.01.007_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/gutjnl-2022-327216","article-title":"Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections","volume":"72","author":"Burm","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ymthe.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.abb7015","article-title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2","volume":"368","author":"Shi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.01.007_bib19","doi-asserted-by":"crossref","first-page":"n1088","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ymthe.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Shinde","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib22","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMc2209306","article-title":"Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.01.007_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41590-022-01292-1","article-title":"Airway-resident T\u00a0cells from unexposed individuals cross-recognize SARS-CoV-2","volume":"23","author":"Diniz","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T\u00a0cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41467-023-40460-1","article-title":"Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T\u00a0cell immunity","volume":"14","author":"Altmann","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.01.007_bib27","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.01.007_bib28","article-title":"A comparative characterization of SARS-CoV-2-specific T\u00a0cells induced by mRNA or inactive virus COVID-19 vaccines","volume":"3","author":"Lim","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ymthe.2024.01.007_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg7015","article-title":"Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates","volume":"8","author":"Routhu","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib30","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1016\/S2666-5247(23)00139-8","article-title":"Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China","volume":"4","author":"Yang","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ymthe.2024.01.007_bib31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.01.007_bib32","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1002\/cti2.1312","article-title":"Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay","volume":"10","author":"Hober","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","article-title":"A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model","volume":"6","author":"Hawman","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.4049\/jimmunol.179.7.4741","article-title":"In\u00a0vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3\/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T\u00a0cells","volume":"179","author":"Ahl\u00e9n","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/mt.2014.233","article-title":"Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination","volume":"23","author":"Brass","year":"2015","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:47:40Z","timestamp":1777618060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1525001624000078"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T\u00a0cells in protection and disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}]}}